USPTO serial 79285864
HELIUS THERAPEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 7, 2021
- Examiner
- STRUCK, ROBERT J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with HELIUS THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sarah P. Harrell
Sarah P. Harrell BARNES & THORNBURG LLP11 S. Meridian St.Indianapolis, IN 46204UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Active chemical ingredients for use in the manufacture of pharmaceuticals solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD | ACTIVE | — |
| 005 | Pharmaceutical preparations for the treatment of pain, appetite loss, epilepsy and seizures, glaucoma, sleep disorders, muscle spasms, nausea, gastrointestinal disorders, cancer, Alzheimer's disease, symptoms of post-traumatic stress disorder, anxiety, depression, schizophrenia, addiction disorder, inflammation, multiple sclerosis, pre-menstrual syndrome; medicinal preparations for the treatment of pain, appetite loss, epilepsy and seizures, glaucoma, sleep disorders, muscle spasms, nausea, gastrointestinal disorders, cancer, Alzheimer's disease, symptoms of post-traumatic stress disorder, anxiety, depression, schizophrenia, addiction disorder, inflammation, multiple sclerosis, pre-menstrual syndrome; herbal preparations and extracts for medicinal use; medical cannabis and derivatives thereof namely, medicinal herbs and medicinal herb extracts; herbal supplements; all of the foregoing containing or solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD | ACTIVE | — |
| 035 | Retail and wholesale store services featuring cannabis medicinal herbs, cannabis oil and derivatives thereof all of the foregoing containing or solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; retail and wholesale store services featuring hemp and cannabis cosmetic products and accessories, food products, beverages, personal care preparations, and skin care preparations, all of the foregoing containing or solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; providing consumer information featuring the ratings, reviews and recommendations on marijuana and medical marijuana products via a website | ACTIVE | — |
| 044 | Cultivation of plants for others featuring solely cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; consultancy services relating to the cultivation of plants; cultivation and breeding for others of cannabis all of the foregoing containing or solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; providing health and agricultural information in the field of medical marijuana and cannabis via a website; providing medical information featuring indications and effects of particular cannabis strains, the benefits of medical marijuana, marijuana, cannabis and research related to cannabis and marijuana via a website | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HELIUS THERAPEUTICS LIMITED
- Other trademarks owned by HELIUS THERAPEUTICS LIMITED
- Other trademarks owned by HELIUS THERAPEUTICS LIMITED
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 044
- Similar marks named HELIUS THERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 2, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 5, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 23, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 23, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 7, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 8, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 18, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 7, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 14, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 27, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 27, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 4, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 21, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 21, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 1, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 1, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 1, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 19, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 16, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 12, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 12, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 12, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 15, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 15, 2021 | ALIE | ASSIGNED TO LIE | — |
| Jul 15, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 15, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 15, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 4, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 4, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 4, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 29, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 29, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 29, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 30, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 30, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 30, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 18, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 30, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 30, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 10, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 9, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 9, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 2, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 28, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| May 27, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| May 27, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 21, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |